文献速递系统性红斑狼疮

血清I型干扰素经STAT1/STAT2促进狼疮患者AIM2炎症小体失调

Serum type I interferon promotes AIM2 inflammasome dysregulation in lupus patients through STAT1 and STAT2.
PubMed 文献 · Rheumatology (Oxford) · 2026-01-01

本研究比较SLE患者与健康对照单核细胞中AIM2炎症小体的表达与功能,发现患者单核细胞AIM2组分及IL-1β、IL-18升高,血清I型干扰素经STAT1/STAT2/IRF9增强AIM2启动子活性,AIM2缺失可减轻狼疮鼠症状。

要点

  • SLE患者单核细胞AIM2炎症小体表达及IL-1β、IL-18产生升高。
  • 血清I型干扰素通过STAT1/STAT2/IRF9促进AIM2基因转录。
  • 单核细胞AIM2缺失可减轻诱导性狼疮小鼠的狼疮样表现。

核心结论

  • 血清I型干扰素通过单核细胞STAT1-STAT2/AIM2炎症小体轴传播SLE固有免疫功能障碍。

研究设计与样本

  • 比较SLE患者与健康对照单核细胞AIM2炎症小体的表达与功能反应。
  • 体外培养原代单核细胞检测影响AIM2炎症小体反应的血清学因素。
  • 采用RNA测序、生物信息学分析和ChIP-qPCR鉴定介导失调的下游分子靶点。
  • 使用诱导性狼疮小鼠模型评估单核细胞AIM2失调对SLE发展的病理影响。

主要发现

  • SLE患者单核细胞AIM2炎症小体组分表达升高,IL-1β和IL-18产生增加。
  • SLE患者血清和重组IFN-α可通过上调AIM2表达促进AIM2炎症小体活性。
  • SLE单核细胞中STAT1和STAT2表达及活化增加,促进STAT1、STAT2和IRF9结合AIM2启动子ISRE样位点。
  • 单核细胞AIM2缺陷减轻狼疮小鼠的SLE样特征。

临床怎么用

  • 提示监测SLE患者单核细胞AIM2炎症小体活化及I型干扰素水平可能有助于评估固有免疫失调。
  • 靶向STAT1-STAT2/AIM2轴或为干预SLE单核细胞固有免疫功能障碍的潜在方向。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The Absent in Melanoma 2 (AIM2) inflammasome is a crucial producer of IL-1β and IL-18 upon sensing double-stranded (ds)DNA but its role in SLE remains ambiguous. The study aims to investigate the involvement and underlying mechanism leading to AIM2 inflammasome dysregulation in lupus patients. METHODS: Expression and functional response of AIM2 inflammasome in monocytes were compared between SLE patients and healthy controls. Serological factors affecting AIM2 inflammasome response were tested by in vitro culture of primary monocytes. RNA sequencing, bioinformatics analyses and chromatin-immunoprecipitation-coupled (ChIP)-qPCR were performed to identify downstream molecular targets mediating the dysregulation. The pathological impact of monocytic AIM2 dysregulation on SLE development was evaluated using an induced-lupus mouse model. RESULTS: Monocytes of SLE patients exhibited elevated expression of AIM2 inflammasome components and elevated IL-1β and IL-18 production. SLE patients' sera and recombinant interferon (IFN)-α could promote AIM2 inflammasome activity through augmenting AIM2 expression. Mechanistically, through increasing the expression and activation of signal transducer and activator of transcription (STAT) 1 and STAT2 in SLE monocytes, serum type-I IFN facilitated binding of STAT1, STAT2 and IRF9 to IFN-stimulated regulatory element (ISRE)-like sites in AIM2 promoter, thereby inducing higher AIM2 gene expression. Deficiency of AIM2 in monocytes alleviated SLE-like features in lupus mice. CONCLUSION: A novel pathway by which serum type-I IFN propagates innate immune dysfunction in SLE via the STAT1-STAT2/AIM2 inflammasome axis in monocytes has been revealed.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Chow JX, Zhu H, Jiang J, et al. Serum type I interferon promotes AIM2 inflammasome dysregulation in lupus patients through STAT1 and STAT2. Rheumatology (Oxford). 2026. PMID: 41693021. doi:10.1093/rheumatology/keag095

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。